Strengthening MedTech Europe’s voice: highlights from recent EU engagements

Posted on 03.07.2025

MedTech Europe continues to provide members with unique opportunities to engage at the highest levels of EU policymaking.

On 10 June 2025, a delegation of MedTech Europe members met with EU Health Commissioner Olivér Várhelyi to discuss the urgent need for structural reform of the Medical Devices Regulation and In Vitro Diagnostics Regulation framework and the impact of US tariffs on European medical technology. The meeting reinforced our call fora predictable, innovation-friendly regulatory environment to support Europe’s competitiveness and patient access to new technologies.

On 23 June 2025, MedTech Europe members met with EU Commissioner for Startups, Research and Innovation, Ekaterina Zaharieva, to explore how public and private investments—particularly through the Horizon Europe Programme—can strengthen the EU research and innovation ecosystem. We emphasised the importance off fostering collaboration among patient organisations, SMEs, competent authorities, and industry, and attracting global investment to ensure Europe remains at the forefront of health innovation.

A highlight on 2 July 2025 was the keynote speech by Lorena Boix Alonso, Deputy Director General for Health at DG SANTE, at our CEO Summit in Brussels. Her intervention underscored the strategic importance of medical technology for Europe’s health and competitiveness.

These engagements reflect our commitment to shaping a future-ready, innovative, and resilient medical technology sector in Europe.

For further information, please contact Melanie Wahl, Senior Policy Advisor.